Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies

Early Human Development

Volumn 88, Issue 6, 2012, Pages 375-378

  van der Lugt, N Margreth ^a   van de Maat, Josephine S ^a   van Kamp, Inge L ^a   Knoppert van der Klein, Elise A M ^b   Hovens, Jacqueline G F M ^a   Walther, Frans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Rivierduinen ^*  (Netherlands)

Author keywords

Bipolar disorder; Child; Lithium; Neurodevelopmental outcome; Pregnancy

Indexed keywords

FLUOXETINE; HALOPERIDOL; LITHIUM; LORAZEPAM; NORTRIPTYLINE;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CHILD; CHILD BEHAVIOR; CHILD BEHAVIOR CHECKLIST; CHILD DEVELOPMENT; COGNITION; COHORT ANALYSIS; FEMALE; FETUS DEVELOPMENT; HUMAN; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; INTELLIGENCE QUOTIENT; LITHIUM BLOOD LEVEL; MALE; MUSCLE HYPOTONIA; NAUSEA AND VOMITING; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; PARENT; PERINATAL DEVELOPMENT; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRESCHOOL CHILD; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMAN DEVELOPMENT; HUMANS; LITHIUM COMPOUNDS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES;

EID: 84860531133     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.09.013     Document Type: Article

References (26)

1. Kennedy N., Boydell J., Kalidindi S., Fearon P., Jones P.B., van Os J., et al. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry 2005, 162:257-262.
2. Viguera A.C., Cohen L.S., Baldessarini R.J., Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 2002, 47:426-436.
3. Viguera A.C., Whitfield T., Baldessarini R.J., Newport D.J., Stowe Z., Reminick A., et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007, 164:1817-1824.
4. Viguera A.C., Nonacs R., Cohen L.S., Tondo L., Murray A., Baldessarini R.J. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000, 157:179-184.
5. Newport D.J., Viguera A.C., Beach A.J., Ritchie J.C., Cohen L.S., Stowe Z.N. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005, 162:2162-2170.
6. Weinstein M.R. The international register of lithium babies. Drug Inf J 1976, 10:94-100.
7. Jacobson S.J., Jones K., Johnson K., Ceolin L., Kaur P., Sahn D., et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992, 339:530-533.
8. Zalzstein E., Koren G., Einarson T., Freedom R.M. A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly. Am J Cardiol 1990, 65:817-818.
9. Cohen L.S., Friedman J.M., Jefferson J.W., Johnson E.M., Weiner M.L. A reevaluation of risk of in utero exposure to lithium. JAMA 1994, 271:146-150.
10. Kozma C. Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: another clinical report and a review of the literature. Am J Med Genet A 2005, 132:441-444.
11. Pinelli J.M., Symington A.J., Cunningham K.A., Paes B.A. Case report and review of the perinatal implications of maternal lithium use. Am J Obstet Gynecol 2002, 187:245-249.
12. Simone C., Derewlany L.O., Koren G. Drug transfer across the placenta. Considerations in treatment and research. Clin Perinatol 1994, 21:463-481.
13. Carlezon W.A., Konradi C. Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 2004, 47(Suppl. 1):47-60.
14. Tueth M.J., Murphy T.K., Evans D.L. Special considerations: use of lithium in children, adolescents, and elderly populations. J Clin Psychiatry 1998, 59(Suppl. 6):66-73.
15. Youngs R.M., Chu M.S., Meloni E.G., Naydenov A., Carlezon W.A., Konradi C. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J Neurosci 2006, 26:6031-6039.
16. Schou M. What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 1976, 54:193-197.
17. Gentile S. Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety 2010, 27:675-686.
18. Koren G., Bologa M., Long D., Feldman Y., Shear N.H. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol 1989, 160:1190-1194.
19. Hempel M.S. Neurological development during toddling age in normal children and children at risk of developmental disorders. Early Hum Dev 1993, 34:47-57.
20. Touwen B.C.L. Examination of the child with minor neurological dysfunction. Clin Dev Med No 1979, 71. Mac Keith Press, London.
21. Peters L.H., Maathuis K.G., Kouw E., Hamming M., Hadders-Algra M. Test-retest, inter-assessor and intra-assessor reliability of the modified Touwen examination. Eur J Paediatr Neurol 2008, 12:328-333.
22. Bayley N. Bayley Scales of Infant and Toddler Development 2009, Pearson, San Antonio. 3rd ed.
23. Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-Revised 1989, The Psychological Corporation, New York.
24. Wechsler D. Wechsler Intelligence Scale for Children Third Edition Manual 1991, Psychological Corporation, New York.
25. Achenbach T.M. Manual for the child behavior checklist/4-18 and 1991 profiles 1991, University of Vermont, Department of Psychiatry, Burlington, Virginia, USA.
26. Gentile S. SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome. CNS Drugs 2005, 19:623-633.